首页 | 本学科首页   官方微博 | 高级检索  
文章检索
  按 检索   检索词:      
出版年份:   被引次数:   他引次数: 提示:输入*表示无穷大
  收费全文   21202篇
  免费   769篇
  国内免费   1513篇
系统科学   513篇
丛书文集   717篇
教育与普及   120篇
理论与方法论   24篇
现状及发展   707篇
研究方法   1篇
综合类   21391篇
自然研究   11篇
  2024年   29篇
  2023年   104篇
  2022年   205篇
  2021年   242篇
  2020年   255篇
  2019年   247篇
  2018年   258篇
  2017年   339篇
  2016年   409篇
  2015年   545篇
  2014年   888篇
  2013年   666篇
  2012年   1154篇
  2011年   1325篇
  2010年   1137篇
  2009年   1395篇
  2008年   1327篇
  2007年   1682篇
  2006年   1502篇
  2005年   1293篇
  2004年   1139篇
  2003年   1063篇
  2002年   880篇
  2001年   715篇
  2000年   680篇
  1999年   660篇
  1998年   420篇
  1997年   429篇
  1996年   361篇
  1995年   337篇
  1994年   302篇
  1993年   289篇
  1992年   265篇
  1991年   253篇
  1990年   189篇
  1989年   179篇
  1988年   119篇
  1987年   86篇
  1986年   49篇
  1985年   50篇
  1984年   11篇
  1981年   4篇
  1980年   1篇
  1955年   1篇
排序方式: 共有10000条查询结果,搜索用时 15 毫秒
11.
目的:探讨乙酰胆碱对人胃粘膜上皮细胞和胃腺癌细胞内Ca2 、Mg2 浓度的影响。方法:利用大型生化分析仪,检测了乙酰胆碱作用后培养的人胃粘膜上皮细胞和胃腺癌细胞内Ca2 、Mg2 的浓度。结果:与正常胃粘膜上皮细胞比较,胃腺癌细胞内Ca2 、Mg2 浓度偏低(P>0 01)。在乙酰胆碱作用下,胃粘膜上皮细胞内Ca2 浓度升高(P<0 01),Mg2 浓度降低(P<0 01);胃腺癌细胞仅有Ca2 浓度升高(P<0 05),Mg2 浓度无变化。阿托品能阻断乙酰胆碱的作用(P<0 05)。结论:乙酰胆碱对胃粘膜上皮细胞和胃腺癌细胞的作用是通过毒蕈碱受体实现的。  相似文献   
12.
在探索综合性大学中教师教育的培养模式研究过程中,根据教师教育双专业的特性,实施了综合性大学师范本科教育3+1课程方案和培养模式的研究与实践.并以化学教师教育培养为例对3+1模式的作了具体说明.  相似文献   
13.
以H-(CH2)n-CH=CH2和H-(CH2)n-C≡CH型同系物结构重复单元数值连续变化为模型,获得了描述该同系物凝聚型物理性质递变规律的数学表达式:P=(a0+a1n+a2n2)/(1+b2n2),式中a0、a1、a2、b2均为常数,n为结构重复单元数值,P为同系物的凝聚型物理性质。通过非线性回归分析,得到回归方程,结果表明同系物的凝聚型物理性质与重复结构单元数值之间满足上述关系式,并显示优良的相关性。  相似文献   
14.
关于图的第二特征标R2(G)   总被引:10,自引:2,他引:8  
对任意图G,h(G,x)表示图G的伴随多项式,R2(G)表示图G的第二特征标,本文刻画了R2(G)=-2,-1,0,1,2的全部连通图。  相似文献   
15.
本文采用卡诺图列解法来处理MUX组件的地址变量少于待发生逻辑函数变量的设计问题。方法简单易行、适用范围广。尤其是对于含有任意项的逻辑函数中任意项的处理,提供了寻找最佳方案的途径。  相似文献   
16.
为探讨穴位注射维生素B1佐治小儿腹泻的价值,对1995~2000年收治的178例小儿腹泻患者进行足三里穴位注射维生素B1治疗100例(观察组)与常规治疗78例进行对照,结果两组止泻天数间有显著差异(P<0.01).  相似文献   
17.
谢玲  徐志明 《贵州科学》2002,20(4):147-148
本文介绍了一种增加GDX1卷烟包装机缺商标纸检测可靠性的方法。  相似文献   
18.
It has been proposed that activation of Toll-like receptors (TLRs) plays crucial roles in the polarization of adaptive immune responses. A synthetic Toll-like receptor 2 (TLR2) ligand, Pam3CSK4, has been reported to modulate the balance of Th1/Th2 responses. We evaluated the modulation effect of Pam3CSK4 on allergic immune response in a mouse rhinitis model sensitized to house dust mite allergen (HDM). Mice were sensitized and challenged with Dermatophagoidesfarinae allergen (Der f), and then the allergic mice were treated by Pam3CSK4. Nasal allergic symptoms and eosinophils were scored. Der f-specific cytokine responses were examined in the splenocytes and bronchoalveolar lavage fluid (BALF). Serum level of total IgE was also detected. After establishing a mouse allergic rhinitis model with HDM, we have showed that Pam3CSK4 treatment not only ameliorated the nasal allergic symptoms remarkably but also decreased the eosinophils and total inflammation cells in BALF significantly. Analysis of cytokine profile found that IFN-7 released from either BALF or stimulated splenocytes increased markedly in Pam3CSK4-treated mice, while IL-13 decreased significantly. Moreover, serum level of total IgE was significantly lower in Pam3CSK4-treated mice than in the untreated. Thus, in an allergic rhinitis mouse model developed with HDM, Pam3CSK4 was shown to exhibit an antiallergic effect, indicating its potential application in allergic diseases.  相似文献   
19.
基于GM(1,1)模型的某高校招生人数预测   总被引:1,自引:0,他引:1  
分析了近年来我国高校招生人数的变化趋势,并利用GM(1,1)模型对某高校2008年的招生人数进行了预测.从而为高校招生人数决策提供了依据。  相似文献   
20.
The purposes of this research were to study the stable expression of exogenous gene encoding therapeutic protein in attenuated Salmonella typhimurium, observe the metabolism of oral gene vaccine carried by attenuated Salmonella typhimurium in BALB/c mouse, and investigate the feasibility of prevention and treatment of tumors by the recombinant bacteria. Recombinant plasmid pcDNA3.1 VEGFR2(n1-7) was transformed into competent attenuated Salmonella typhimurium SL3261 to develop oral DNA vaccine SL3261-pcDNA3.1 VEGFR2(n1-7). To observe whether the exogenous gene can be expressed in the recombinant bacteria, PCR was performed to amplify the CMV promoter of the eukaryotic expression vector as the proof of stable expression of exogenous protein; transmission elec- tron microscopy (TEM) was applied to observe the morphology of the recombinant bacteria to confirm that the exogenous gene has no impact on the growth of the bacteria, and then BALB/c mice were immunized with the gene vaccine. After inoculation of the gene vaccine, the recombinant bacteria SL3261 could be detected in the tissues such as small intestine, colon, liver and spleen. And then, mice in each group were challenged with tumor cells. The results of animal experiment showed that tumor growth of the mice in experimental group was inhibited and survival time of immunized mice was prolonged compared with control groups. A higher lymphocyte infiltration in tumors from animals treated with DNA vaccine was observed. Immunohistochemical analysis of tumor samples revealed an en- hanced accumulation of CD8 cytotoxic T lymphocytes, as well as an increase in CD4 cells in the tumors of animals treated with the oral gene vaccine compared to tumors from control group mice. Ultrastructure of the tumor tissue showed that tumor cells in the samples of the immunized mice were well-differentiated. Our research confirmed that the exogenous gene can be stably expressed in the attenuated Salmonella typhimurium and has no impact on the growth of the recombinant bacteria; the exogenous gene can de delivered to the host by attenuated Salmonella typhimurium to produce anti-tumor effect with no obvious cytotoxity to the host. In this study, it is established that attenuated Salmonella typhimurium could be used as a vector for oral gene vaccine, and our study provided a theoretical basis for the body distribution and the metabolism of the recombinant bacteria. This strategy may provide a simple, safe and effective way for the prevention and treatment of tumors.  相似文献   
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号